Recanalization Rate and Clinical Outcomes of Intravenous Tissue Plasminogen Activator Administration for Large Vessel Occlusion Stroke Patients

OBJECTIVE: Stroke caused from large vessel occlusion (LVO) has emerged as the most common stroke subtype worldwide. Intravenous tissue plasminogen activator administration (IV-tPA) and additional intraarterial thrombectomy (IA-Tx) is regarded as standard treatment. In this study, the authors try to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Min-Hyung, Im, Sang-Hyuk, Jo, Kwang Wook, Yoo, Do-Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurosurgical Society 2023
Materias:
Clinical Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009240/
https://www.ncbi.nlm.nih.gov/pubmed/36825298
http://dx.doi.org/10.3340/jkns.2022.0120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009240/
https://www.ncbi.nlm.nih.gov/pubmed/36825298
http://dx.doi.org/10.3340/jkns.2022.0120

Ejemplares similares